NRXP
NRX PHARMACEUTICALS INC
1 day chart
About NRXP
NRX Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the development of therapeutics for the treatment of central nervous system disorders, specifically suicidal depression and post-traumatic stress disorder (PTSD). The Company’s program NRX-101, an oral, fixed-dose combination of D-cycloserine and lurasidone, targets the brains N-methyl-D-aspartate (NMDA) receptor and is being investigated in a Phase III trial under the United States Food and Drug Administrations (FDA) Special Protocol Agreement and Therapy Designation in patients with bipolar depression and suicidal ideation. The Company has also initiated a Phase IIb clinical trial in patients with Sub-Acute Suicidality, a substantially broader indication. Its product, NRX-100, is racemic ketamine, which is a generic anesthetic. It is engaged in the development of aviptadil acetate (ZYESAMI) for the treatment of respiratory failure in COVID-19.
Buy US stocks in Australia starting with NRXP. Open an account and start investing today!
$21.42M
-
0.00%
542.7K
$0.27
$0.24
$0.25
$1.54
$0.22
NRXP FAQs
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake Wall St
- Deposit directly into your Stake wallet and you're ready to invest in NRXP
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.